Cytoplasmic versus nuclear THR alpha expression determines survival of ovarian cancer patients

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch

Erschienen in
In: Journal of Cancer Research and Clinical Oncology, 146, 8, S. 1923-1932

Ereignis
Veröffentlichung
(wo)
Augsburg
(wer)
Universität Augsburg, Springer Science and Business Media LLC
(wann)
2020
Urheber
Ditsch, Nina
Heublein, Sabine
Jeschke, Udo
Sattler, Cornelia
Kuhn, Christina
Hester, Anna
Czogalla, Bastian
Trillsch, Fabian
Mahner, Sven
Engel, Jutta
Mayr, Doris
Schmoeckel, Elisa

DOI
10.1007/s00432-020-03241-7
URN
urn:nbn:de:bvb:384-opus4-776666
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
25.03.2025, 13:51 MEZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Ditsch, Nina
  • Heublein, Sabine
  • Jeschke, Udo
  • Sattler, Cornelia
  • Kuhn, Christina
  • Hester, Anna
  • Czogalla, Bastian
  • Trillsch, Fabian
  • Mahner, Sven
  • Engel, Jutta
  • Mayr, Doris
  • Schmoeckel, Elisa
  • Universität Augsburg, Springer Science and Business Media LLC

Entstanden

  • 2020

Ähnliche Objekte (12)

Cytoplasmic localization of RXRα determines outcome in breast cancer

Cytoplasmic localization of RXRα determines outcome in breast cancer

Cytoplasmic VDR expression as an independent risk factor for ovarian cancer

Cytoplasmic VDR expression as an independent risk factor for ovarian cancer

Repositionierung von Disulfiram zur Therapie des Ovarialkarzinoms

Hochschulschrift

Repositionierung von Disulfiram zur Therapie des Ovarialkarzinoms

THR alpha and its subtypes alpha1 and alpha2 are prognostic markers for survival of ovarian cancer patients

THR alpha and its subtypes alpha1 and alpha2 are prognostic markers for survival of ovarian cancer patients

Seasonal dynamic of cholecalciferol (D3) and anti-Muellerian hormone (AMH) with impact on ovarian response and IVF/ICSI

Seasonal dynamic of cholecalciferol (D3) and anti-Muellerian hormone (AMH) with impact on ovarian response and IVF/ICSI

Subcellular distribution of thyroid hormone receptor beta in ovarian cancer

Subcellular distribution of thyroid hormone receptor beta in ovarian cancer

Grundstücksakten THR 813, THR 814, THR 815, THR 816, THR 817, THR 818, THR 821, THR 822, THR 834, THR 836, THR 837, THR 838, THR 839, THR 840, THR 841

Schriftgut

Grundstücksakten THR 813, THR 814, THR 815, THR 816, THR 817, THR 818, THR 821, THR 822, THR 834, THR 836, THR 837, THR 838, THR 839, THR 840, THR 841

Hormone receptor expression in multicentric/multifocal versus unifocal breast cancer: especially the VDR determines the outcome related to focality

Hormone receptor expression in multicentric/multifocal versus unifocal breast cancer: especially the VDR determines the outcome related to focality

Grundstücksakten THR 893, THR 894, THR 895, THR 896, THR 897, THR 898, THR 899, THR 900, THR 901, THR 902, THR 903, THR 904

Schriftgut

Grundstücksakten THR 893, THR 894, THR 895, THR 896, THR 897, THR 898, THR 899, THR 900, THR 901, THR 902, THR 903, THR 904

Grundstücksakten THR 824, THR 825, THR 826, THR 827, THR 828, THR 829, THR 830, THR 831, THR 832, THR 833

Schriftgut

Grundstücksakten THR 824, THR 825, THR 826, THR 827, THR 828, THR 829, THR 830, THR 831, THR 832, THR 833

Trace amine-associated receptor 1 (TAAR1) is a positive prognosticator for epithelial ovarian cancer

Trace amine-associated receptor 1 (TAAR1) is a positive prognosticator for epithelial ovarian cancer

Grundstücksakten THR 5, THR 6, THR 10, THR 11, THR 12, THR 13

Schriftgut

Grundstücksakten THR 5, THR 6, THR 10, THR 11, THR 12, THR 13

Verbundene Objekte